Analyzed by flow cytometry, the median percentage of Tim-3+PD-1+ cells among CD8+ T cells in CRC patients was significantly higher than that in the normal volunteers(3.12% vs 1.99%, p = 0.0403, Figure 1F). This evidence concerns the gene CD8A and colorectal carcinoma.